⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9704318 | 0.77 | — | — | |
| SCHEMBL11828570 | 0.77 | — | — | |
| SCHEMBL8979662 | 0.77 | — | — | |
| SCHEMBL25393144 | 0.73 | APLNR (0.41) | — | |
| SCHEMBL9625850 | 0.71 | GPR119 (0.30) | — | |
| SCHEMBL11207418 | 0.70 | — | — | |
| SCHEMBL10779437 | 0.70 | — | — | |
| SCHEMBL7758022 | 0.69 | GAA (0.53) | — | |
| SCHEMBL22127835 | 0.67 | GAA (0.48) | — | |
| Hydrochloric Acid SCHEMBL9108809 | 0.67 | GAA (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1077695-A2 | COMPOUNDS HAVING IgE AFFECTING PROPERTIES | Avanir Pharmaceuticals (US) | 2001-02-28 | — | — | EP | claimed |
| WO-1999061013-A2 | COMPOUNDS HAVING IgE AFFECTING PROPERTIES | AVANIR PHARMACEUTICALS (US) | 1999-12-02 | — | — | WO | claimed |
| US-6451829-B2 | ANTIALLERGENS, ANTIHISTAMINE | SIRCAR JAGADISH C (US) | 2002-09-17 | — | — | US | disclosed |
| US-20020010343-A1 | Compounds having IgE affecting properties | SIRCAR JAGADISH C (US) | 2002-01-24 | — | — | US | disclosed |
| US-6271390-B1 | Suppression of the IgE-dependent allergic response by benzimidazole analogs | AVANIR PHARMACEUTICALS | 2001-08-07 | — | — | US | disclosed |